おかえりなさい
Click “ログイン” to agree to Cointime’s 利用規約 and acknowledge that Cointime’s プライバシーポリシー applies to you.
アカウント登録
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">利用規約</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">プライバシーポリシー</a> applies to you.
siteでログインする
siteで登録する
あなたのメールアドレス
受信トレイを確認する
Click the link we sent to to sign in.
Click the link we sent to to sign up.
YZY Bio
company
About
YZY Bio is a biotechnology company that develops anti-tumor bispecific antibodies.
- Wuhan,Hubei,China
- 51 - 100
Details
- Last Funding Type
- Series B
- Last Funding Money Raised
- ¥250M
- Industries
- Biotechnology,Health Care,Pharmaceutical,Product Research
- Founded date
- Jul 1, 2010
- Number Of Employee
- 51 - 100
- Operating Status
- Active
- Legal Name
- Wuhan YZY Biopharma Co., Ltd.
- Also Known As
- 友芝友生物制药,Youzhiyou Biopharmaceuticals
YZY Bio is a biotechnology company that develops anti-tumor bispecific antibodies based on breakthrough discoveries in molecular biology, enabling patients with major diseases to obtain more efficient treatment solutions.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
¥450M
YZY Bio has raised a total of
¥450M
in funding over 2 rounds. Their latest funding was raised on
Jul 4, 2022 from a Series C round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jul 4, 2022 | Series C | ¥200M | — | — | — | Detail |
| Sep 13, 2021 | Series B | ¥250M | 4 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
4
YZY Bio is funded by 4 investors.
TD Capital
and Sanhua Hongdao Investment
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
TD Capital
|
— | Series B |
|
|
— | Series B |
|
|
— | Series B |
BGI Co-Win
|
— | Series B |
Employee Profiles
Number of Employee Profiles
1
YZY Bio has 1 current employee profiles, including
Executive Pengfei Zhou
Executive
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
